Why is it important?
The GOSH BRC funds translational, experimental medicine research. We aim to accelerate translation of basic science discoveries into the basis of childhood rare diseases into clinical research; developing new diagnostics, imaging techniques and treatments, including ‘first in child’ studies, with the ultimate aim of realising patient and economic benefits. This funding call aims to fund a number of projects, primarily aimed at less well established researchers. The project does not need to be within a disease area the BRC currently supports, but chosen projects will be placed within one of the four existing research themes - Gene, Stem and Cellular Therapies (GSCT), Genomics and Systems Medicine (GSM), Novel Therapies for Translation in Childhood Diseases (NT) & Advanced Treatments for Structural Malformation and Tissue Damage (ATSMTD).
Who can apply?
How much money is available?
Development of a human organotypic model of ciliated brain tissue to investigate the impact of intraventricular haemorrhage on brain development in the premature neonate.
Awarded - £25,000